Supplementary Figure S5 from Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T-cell Therapy

Key Points

• Clonal hematopoiesis may predict hematologic toxicity following CAR-T therapy.
• Figure S5 illustrates time to MDS/AML diagnosis correlated with previous treatment lines.
• Linear regression analysis outlines the prediction relationship between therapy history and outcomes.
• Implications suggest monitoring clonal hematopoiesis could guide patient management strategies.